Stem Cell Transplantation

Expanded clonal T cell levels predict favorable response to photopheresis treatment

Published in Blood Weekly, November 7th, 2002

by Michael Greer, senior medical writer - Researchers in the United States have identified a positive prognostic indicator for patients undergoing photopheresis treatment for graft-versus-host disease after stem cell transplantation.

"Chronic graft-versus-host disease (cGvHD) is a multiorgan disorder with skin manifestations resembling scleroderma," explained Lars E. French and colleagues at the University of Pennsylvania in Philadelphia and Tufts New England Medical Center in Boston.

Amplified clonal T cell populations after stem cell transplantation predict a favorable outcome after photopheresis treatment for cGvHD, French and coauthors...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2002-11-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry